#$%^&*AU2020203514A120200618.pdf#####ABSTRACT In certain aspects, the present disclosure relates to polypeptides comprising a truncated, ligand-binding portion of the extracellular domain of TRII polypeptide useful to selectively antagonize a TjRII ligand. The disclosure further provides compositions and 5 methods for use in treating or preventing TGFP associated disorders.